A Study to Assess the Bioequivalence of Aprepitant and Fosaprepitant and the Effect of Food on Aprepitant Bioavailability (0869-165)

Clinical trial NCT00945321 · COMPLETED

Trial details

NCT number: NCT00945321
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chemotherapy-Induced Nausea and Vomiting

Start date: 2009-02-01
Primary completion: 2009-03-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.